156 related articles for article (PubMed ID: 8354306)
1. Comparative in vitro activity of biapenem, a new carbapenem antibiotic.
Clarke AM; Zemcov SJ
Eur J Clin Microbiol Infect Dis; 1993 May; 12(5):377-84. PubMed ID: 8354306
[TBL] [Abstract][Full Text] [Related]
2. In-vitro activity of meropenem against clinical isolates obtained in Canada.
Clarke AM; Zemcov SJ
J Antimicrob Chemother; 1989 Sep; 24 Suppl A():47-55. PubMed ID: 2808216
[TBL] [Abstract][Full Text] [Related]
3. Comparative in vitro activity of FK-037, a new cephalosporin antibiotic.
Clarke AM; Zemcov SJ; Hubinette MM
Diagn Microbiol Infect Dis; 1994 Sep; 20(1):27-32. PubMed ID: 7867295
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial activity of the new carbapenem biapenem compared to imipenem, meropenem and other broad-spectrum beta-lactam drugs.
Sader HS; Jones RN
Eur J Clin Microbiol Infect Dis; 1993 May; 12(5):384-91. PubMed ID: 8354307
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of the novel cephalosporin GR69153.
Clarke AM; Zemcov SJ
Eur J Clin Microbiol Infect Dis; 1991 Aug; 10(8):683-7. PubMed ID: 1748126
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity and beta-lactamase stability of a new penem, CGP 31608.
Neu HC; Chin NX; Neu NM
Antimicrob Agents Chemother; 1987 Apr; 31(4):558-69. PubMed ID: 3496845
[TBL] [Abstract][Full Text] [Related]
7. In-vitro activity of pefloxacin compared to enoxacin, norfloxacin, gentamicin and new beta-lactams.
Clarke AM; Zemcov SJ; Campbell ME
J Antimicrob Chemother; 1985 Jan; 15(1):39-44. PubMed ID: 3156112
[TBL] [Abstract][Full Text] [Related]
8. In-vitro activity of meropenem against clinical isolates in a multicentre study in Italy.
Schito GC; Sanna A; Chezzi C; Ravizzola G; Leone F; Molinari G; Menozzi MG; Pirali F
J Antimicrob Chemother; 1989 Sep; 24 Suppl A():57-72. PubMed ID: 2681128
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial activity of imipenem against 1386 clinical isolates.
Belobraydic KA; Qadri SM
Methods Find Exp Clin Pharmacol; 1986 Nov; 8(11):675-8. PubMed ID: 3468319
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of three carbapenem antibiotics. Comparative studies with biapenem (L-627), imipenem, and meropenem against aerobic pathogens isolated worldwide.
Hoban DJ; Jones RN; Yamane N; Frei R; Trilla A; Pignatari AC
Diagn Microbiol Infect Dis; 1993; 17(4):299-305. PubMed ID: 8112045
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity and beta-lactamase stability of a new carbapenem, SM-7338.
Neu HC; Novelli A; Chin NX
Antimicrob Agents Chemother; 1989 Jul; 33(7):1009-18. PubMed ID: 2789493
[TBL] [Abstract][Full Text] [Related]
12. In vitro activity of Biapenem plus RPX7009, a carbapenem combined with a serine β-lactamase inhibitor, against anaerobic bacteria.
Goldstein EJ; Citron DM; Tyrrell KL; Merriam CV
Antimicrob Agents Chemother; 2013 Jun; 57(6):2620-30. PubMed ID: 23529731
[TBL] [Abstract][Full Text] [Related]
13. Comparative in-vitro activity of biapenem against enterobacteria with beta-lactamase-mediated antibiotic resistance.
Chen HY; Livermore DM
J Antimicrob Chemother; 1994 Mar; 33(3):453-64. PubMed ID: 8040111
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of HRE 664, a penem antibiotic.
Chin XN; Neu HC
Diagn Microbiol Infect Dis; 1990; 13(6):509-16. PubMed ID: 2279381
[TBL] [Abstract][Full Text] [Related]
15. Comparative in vitro activity of piperacillin/tazobactam against gram-negative bacilli.
Liebowitz LD; Klugman KP
S Afr Med J; 1996 Oct; 86(10):1276-80. PubMed ID: 8955735
[TBL] [Abstract][Full Text] [Related]
16. [Antibacterial activities of monobactams against fresh clinical isolates].
Deguchi K; Yokota N; Koguchi M; Nakane Y; Fukayama S; Nishimura Y; Oda S; Tanaka S; Kato M; Sato K
Jpn J Antibiot; 1988 Nov; 41(11):1600-22. PubMed ID: 3210297
[TBL] [Abstract][Full Text] [Related]
17. In-vitro antibacterial activity of imipenem compared with four other beta-lactam antibiotics (ceftazidime, cefotaxime, piperacillin and azlocillin) against 828 separate clinical isolates from a Portuguese hospital.
Santos-Ferreira MO; Vital JO
J Antimicrob Chemother; 1986 Dec; 18 Suppl E():23-6. PubMed ID: 3469195
[TBL] [Abstract][Full Text] [Related]
18. [In vitro activity of biapenem (BIPM) against clinically isolated respiratory pathogens in 1996-1998].
Watanabe A; Tokue Y; Takahashi H; Kikuchi T; Kobayashi T; Gomi K; Fujimura S; Yasui S; Nukiwa T; Shoji S; Honda Y
Jpn J Antibiot; 1999 Dec; 52(12):690-4. PubMed ID: 10695024
[TBL] [Abstract][Full Text] [Related]
19. Antibacterial properties of imipenem with special reference to the activity against methicillin-resistant staphylococci, cefotaxime-resistant Enterobacteriaceae and Pseudomonas aeruginosa.
Vurma-Rapp U; Kayser FH; Barberis-Maino L
J Antimicrob Chemother; 1986 Dec; 18 Suppl E():27-33. PubMed ID: 3102452
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of newer broad spectrum beta-lactam antibiotics against enterobacteriaceae and non-fermenters: a report from Austrian intensive care units. Austrian Carbapenem Susceptibility Surveillance Group.
Krause R; Mittermayer H; Feierl G; Allerberger F; Wendelin I; Hirschl A; Reisinger EC
Wien Klin Wochenschr; 1999 Jul; 111(14):549-54. PubMed ID: 10467641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
